The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Family History Biggest Predictor of Heart Attacks in People with Psoriasis

Family History Biggest Predictor of Heart Attacks in People with Psoriasis

July 2, 2016 • By Lisa Rapaport

  • Tweet
  • Email
Print-Friendly Version / Save PDF

(Reuters Health)—People with psoriasis, a chronic inflammatory disease, are more likely to have heart attacks and strokes when they have a family history of cardiovascular problems, a Danish study suggests.

You Might Also Like
  • FDA Rejects Novartis Bid to Repurpose Inflammation Drug for Heart Attacks
  • Patients with Psoriasis, Psoriatic Arthritis at Increased Risk of Migraine
  • Family History Not Linked to Clinical Presentation, Treatment Response of RA

Psoriasis wasn’t associated with higher risk of heart attacks or strokes when people with the skin condition didn’t have a family history of cardiovascular disease, the study found.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

But when people with mild psoriasis and a family history of major adverse cardiac events, such as heart attacks and strokes, were compared with psoriasis sufferers without such a family history, their risk was 28% higher. With severe psoriasis and a family history of heart problems, the risk was 62% higher.

“It is generally believed that patients with psoriasis are at increased risk of cardiovascular disease due to the inflammatory nature of psoriasis,” says lead study author Dr. Alexander Egeberg of the University of Copenhagen.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“While psoriasis itself may still confer an independent cardiovascular risk compared with the general population, our findings suggest that there may exist a genetic predisposition for cardiovascular disease,” Egeberg adds by email.

To assess the link between psoriasis and a family history of heart disease, Egeberg and colleagues reviewed Danish data from 1997–2011 on more than 2.7 million people, including almost 27,000 individuals with mild psoriasis and about 4,500 with severe psoriasis.

At the start of the study, people were around 27 years old on average.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Approximately two-thirds of those with psoriasis in the study had a family history of cardiovascular disease, which was slightly more common with severe psoriasis than with mild psoriasis.

Without a family history of heart disease, the rate of major adverse cardiac events was 1.3 per 10,000 people per year among those who didn’t have psoriasis. That compared with 1.85 cases per 10,000 people per year with mild psoriasis and about 6 per 10,000 with severe psoriasis.

But after researchers adjusted for other factors that might influence the odds of heart attacks and strokes, they no longer found a difference between people with psoriasis and the general population when there was no family history of cardiovascular disease.

There was, however, a significant difference in the risk of heart attacks and strokes when people did have a family history of cardiovascular disease, the researchers report in the Journal of the American Academy of Dermatology.

With a family history, the incidence rates of cardiac events were about 18 per 10,000 people per year for the general population, 36 per 10,000 for mild psoriasis and 45 per 10,000 for severe psoriasis.

Pages: 1 2 | Single Page

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: cardiovascular, heart, Psoriasis

You Might Also Like:
  • FDA Rejects Novartis Bid to Repurpose Inflammation Drug for Heart Attacks
  • Patients with Psoriasis, Psoriatic Arthritis at Increased Risk of Migraine
  • Family History Not Linked to Clinical Presentation, Treatment Response of RA
  • Family, Fatigue & Heart Health

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)